Covered recipient · General Payments record
KATHERINE HEYMAN SAUNDERS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$13,314.58
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $2,921.73 | 8 |
| Food and Beverage | $779.84 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Currax Pharmaceuticals LLC | $2,020.40 | 7 |
| ABBVIE INC. | $1,317.59 | 8 |
| Novo Nordisk AS | $222.95 | 2 |
| PFIZER INC. | $140.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $150.00 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106024977 | CMS |
| ABBVIE INC. | $202.31 | 11/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106024979 | CMS |
| ABBVIE INC. | $62.50 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106024981 | CMS |
| ABBVIE INC. | $48.08 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106024983 | CMS |
| ABBVIE INC. | $22.32 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106024985 | CMS |
| ABBVIE INC. | $726.50 | 11/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106024987 | CMS |
| ABBVIE INC. | $48.20 | 12/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106024989 | CMS |
| ABBVIE INC. | $57.68 | 12/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106024991 | CMS |
| Currax Pharmaceuticals LLC | $290.00 | 02/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1089512260 | CMS |
| Currax Pharmaceuticals LLC | $880.84 | 02/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1089512256 | CMS |
| Currax Pharmaceuticals LLC | $446.20 | 02/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1089512258 | CMS |
| Currax Pharmaceuticals LLC | $270.00 | 02/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1089512262 | CMS |
| Currax Pharmaceuticals LLC | $51.55 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089512250 | CMS |
| Currax Pharmaceuticals LLC | $76.00 | 11/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089512252 | CMS |
| Currax Pharmaceuticals LLC | $5.81 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089512254 | CMS |
| Novo Nordisk Inc | $95.17 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097373579 | CMS |
| Novo Nordisk Inc | $127.78 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097380719 | CMS |
| PFIZER INC. | $140.63 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130972988 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.